- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07710937
Visual and Auditory Electromyography Biofeedback Among Stroke Patients
14. juli 2026 opdateret af: Adnan Hashim, University of Lahore
Comparative Effects of Visual and Auditory Electromyography Biofeedback Combined With Conventional Physiotherapy on Balance, Functional Mobility, Motor Function, and Functional Independence Among Patients With Stroke: A Randomized Controlled Trial
Stroke commonly results in impairments of balance, mobility, and lower extremity motor function that limit independence in daily activities.
Electromyography (EMG) biofeedback enhances motor relearning by providing real-time feedback regarding muscle activation.
Although both visual and auditory EMG biofeedback have demonstrated benefits in stroke rehabilitation, evidence directly comparing these feedback modalities remains limited.
This randomized controlled trial aims to compare the effects of visual and auditory EMG biofeedback, each combined with conventional physiotherapy, on balance, functional mobility, motor function, and functional independence in individuals with stroke.
Studieoversigt
Status
Aktiv, ikke rekrutterende
Betingelser
Detaljeret beskrivelse
This randomized controlled trial will compare two modes of electromyography biofeedback in individuals with stroke undergoing lower extremity rehabilitation.
Eighty-four eligible participants will be randomly allocated into two parallel groups using sealed-envelope randomization.
Both groups will receive conventional physiotherapy consisting of lower extremity strengthening, balance, gait, and task-oriented exercises for 10 minutes per session.
The experimental intervention will consist of either visual or auditory EMG biofeedback applied to the tibialis anterior muscle for 20 minutes.
Treatment will be provided five sessions per week over three weeks (15 sessions).
Outcomes including balance (Berg Balance Scale), functional mobility (Timed Up and Go Test), motor recovery (Fugl-Meyer Assessment-Lower Extremity), and functional independence (Barthel Index) will be assessed at baseline and immediately after completion of the intervention by a blinded assessor.
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
84
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Multan Khurd, Pakistan
- Nishtar Hospital Multan
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- Age between 20 and 30 years
- Male or female participants
- Clinically diagnosed hemiplegic stroke.
- Medically stable and able to participate in rehabilitation.
- No visual impairment that would interfere with visual biofeedback.
- No hearing impairment that would interfere with auditory biofeedback.
- No sensory aphasia affecting the ability to understand study instructions.
Exclusion Criteria:
- Traumatic injury or lesion affecting the lower extremities
- Lower-limb amputation
- Severe systemic disease that could interfere with participation
- Peripheral vascular disease affecting the lower extremities
- Fixed ankle contracture
- Motion sickness or intolerance to rehabilitation technology
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Visual EMG Biofeedback + Conventional Physiotherapy
Participants assigned to this arm will receive 10 minutes of conventional physiotherapy followed by 20 minutes of visual electromyography (EMG) biofeedback training.
Surface EMG electrodes will be applied to the tibialis anterior muscle of the affected lower extremity.
Real-time visual feedback displayed on a monitor will guide voluntary muscle activation to improve balance, motor recovery, functional mobility, and functional independence.
Treatment will be provided for 30 minutes per session, five sessions per week for three weeks (15 sessions).
|
Surface electromyography biofeedback will provide real-time visual feedback of muscle activity from the tibialis anterior muscle using graphical displays on a monitor.
Participants will perform task-oriented lower extremity exercises while observing muscle activation to facilitate motor relearning and improve balance, functional mobility, and lower extremity motor function.
The intervention will be delivered for 20 minutes per session, five sessions per week for three weeks.
Conventional physiotherapy will consist of lower extremity strengthening exercises, task-oriented functional training, balance exercises, gait training, stretching, and mobility exercises.
All participants will receive 10 minutes of conventional physiotherapy before EMG biofeedback during each treatment session.
The intervention will be delivered five sessions per week for three weeks.
|
|
Eksperimentel: Auditory EMG Biofeedback + Conventional Physiotherapy
Participants assigned to this arm will receive 10 minutes of conventional physiotherapy followed by 20 minutes of auditory electromyography (EMG) biofeedback training.
Surface EMG electrodes will be applied to the tibialis anterior muscle of the affected lower extremity.
Muscle activation will be translated into real-time auditory cues to facilitate voluntary muscle contraction, motor relearning, and improvement in balance and functional mobility.
Treatment will be provided for 30 minutes per session, five sessions per week for three weeks (15 sessions).
|
Conventional physiotherapy will consist of lower extremity strengthening exercises, task-oriented functional training, balance exercises, gait training, stretching, and mobility exercises.
All participants will receive 10 minutes of conventional physiotherapy before EMG biofeedback during each treatment session.
The intervention will be delivered five sessions per week for three weeks.
Surface electromyography biofeedback will provide real-time auditory feedback corresponding to muscle activation of the tibialis anterior muscle.
Participants will perform task-oriented lower extremity exercises while using auditory cues to facilitate muscle activation, movement coordination, and motor recovery.
The intervention will be delivered for 20 minutes per session, five sessions per week for three weeks.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Balance (Berg Balance Scale)
Tidsramme: Baseline and Week 3 (Post-intervention)
|
Balance will be assessed using the Berg Balance Scale (BBS), a 14-item performance-based measure of static and dynamic balance.
Scores range from 0 to 56, with higher scores indicating better balance performance.
|
Baseline and Week 3 (Post-intervention)
|
|
Functional mobility (Timed Up and Go Test)
Tidsramme: Baseline and Week 3 (Post-intervention)
|
Functional mobility will be assessed using the Timed Up and Go (TUG) Test.
The time (seconds) required to stand from a chair, walk 3 meters, turn, return, and sit will be recorded.
Lower completion times indicate better functional mobility.
|
Baseline and Week 3 (Post-intervention)
|
|
Motor function (Fugl-Meyer Assessment-Lower Extremity)
Tidsramme: Baseline and Week 3 (Post-intervention)
|
Motor function will be assessed using the Fugl-Meyer Assessment-Lower Extremity (FMA-LE).
The FMA-LE contains 17 items with a total score ranging from 0 to 34.
Higher scores indicate greater motor recovery.
|
Baseline and Week 3 (Post-intervention)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Functional independence (Barthel Index)
Tidsramme: Baseline and Week 3 (Post-intervention)
|
Functional independence will be assessed using the Barthel Index (BI).
The BI evaluates independence in activities of daily living, with scores ranging from 0 to 100.
Higher scores indicate greater functional independence.
|
Baseline and Week 3 (Post-intervention)
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
9. april 2026
Primær færdiggørelse (Anslået)
10. september 2026
Studieafslutning (Anslået)
12. oktober 2026
Datoer for studieregistrering
Først indsendt
14. juli 2026
Først indsendt, der opfyldte QC-kriterier
14. juli 2026
Først opslået (Faktiske)
17. juli 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
17. juli 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
14. juli 2026
Sidst verificeret
1. juli 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- UOL/IREB/26/19/01/0002
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
IPD-planbeskrivelse
Individual participant data will not be shared because this study was conducted as an academic research project.
The informed consent obtained from participants did not include provisions for public data sharing, and the dataset contains sensitive personal health information.
Data will be stored securely and used only for academic and research purposes in accordance with institutional ethics approval.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .